US Edition
Elephants don’t gallop – except for AstraZeneca
Questor share tip: the company’s growth rate and valuation suggest further capital gains are ahead
Advertisement
-
This oil giant may no longer be a contrarian buy but we’ll stick with it for its ample cash flows
Questor share tip: the company’s returns to investors beat the Bank Rate, inflation and gilt yields
-
This super-cheap oil stock is the toast of the world’s top ‘value’ investors
Questor share tip: British investors should look beyond Shell and BP if they want to own the most promising oil giant
-
Our stock holdings still offer long-term growth potential despite sticky inflation
Questor Wealth Preserver: inflation’s eventual fall should get these two underperforming shares moving
-
This trust has some prize assets – what a shame it has to sell them to get on top of its debts
Questor investment trust bargain: Like Hipgnosis Songs Fund, Digital 9 Infrastructure borrowed too much in pursuit of its assets
-
Now is not the right time to bank our 36pc gain on this FTSE 100 stock
Questor share tip: the company’s long-term growth potential means it remains a worthwhile buy
-
If you are an aggressive, risk-tolerant investor, it’s worth holding on to these shares
Questor share tip: This company is looking cheap if it can deliver on its aim of a return to pre-pandemic profitability
-
Why we are buying back into this stock just a year after we bailed out
Questor share tip: The chipmaker, a favourite among the world’s top fund managers, is recovering after a period of depressed demand
-
This iconic drinks brand is a worthy new addition to our IHT portfolio
Questor Inheritance Tax Portfolio: the company’s solid financial position and growth potential offer a favourable risk/reward opportunity
Advertisement
-
This trust has paid dividends that amount to a third of our purchase price
Questor Income Portfolio: A wide discount to net asset value also suggests that the fund is grossly undervalued
-
A collection of excellent assets trapped in a poorly managed fund. Our advice: vote for change
Questor investment trust bargain: Hipgnosis Songs Fund has got itself into a terrible mess; it’s up to shareholders to fix it
-
This acquisitive company is snapping up cheap assets – investors should do the same with its shares
Questor share tip: Diploma has bought a string of businesses without jeopardising its financial strength
-
GSK is winning its legal battles, yields 4pc and is far cheaper than rivals
Questor share tip: While it's not out of the legal woods yet, several cases have been dismissed and momentum is building day-to-day
-
After a tenfold gain on a drugs maker, here is that investor’s next choice
Questor share tip: The Swiss pharmaceutical company appears to offer the same potential that Eli Lilly did before its 987pc gain
-
Forecasts are a rotten basis for investment decisions – except for this one
Questor wealth preserver: One thing we can be reasonably sure of is demographic change – this is the fund to benefit from it
-
This Terry Smith trust has fallen like a stone. Is it now good value?
Questor investment trust bargain: Smithson certainly owns good companies but we must also consider their valuation
-
This stock looked expensive when we tipped it but it has gone on to gain 15pc
Questor share tip: A rich valuation is no barrier to further share price rises if the business is good enough
